Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03720743
Other study ID # amuelle
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2018
Est. completion date June 1, 2018

Study information

Verified date October 2018
Source Universidad de Almeria
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

the objective of this study was to examine the effects of a 10 weeks biodanza program on the sexual desire and inhibition/arousal of a sample of healthy young adults.

A randomized clinical study was carried out, involving a total of 86 young adults divided into Intervention Group (BG) and Control Group (CG), carrying out biodanza sessions during 10 weeks. The Sexual Desire Inventory (SDI) and the Sexual Inhibition/Sexual Arousal-Short Form Scale (SIS/SES-SF) were completed before and after the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date June 1, 2018
Est. primary completion date March 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- at least 18 years old

- having correctly completed the online questionnaire.

- to attend a minimum of eight Biodanza sessions.

Exclusion Criteria:

- exceed 30 years old.

- the presence of some type of physical or mental disability that could prevent their participation in the therapy or the completion of the questionnaires.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Biodanza
Intervention group received a total of 10 sessions, once a week, over the course of two months. Each session lasted 60 minutes. All sessions began with a 10-minute warm-up period combining music and low-intensity movements as a welcome round, followed individual exercises, in pairs and/or groups, which included dance combined with exercises based on the five lines of Biodanza (vitality, sexuality, creativity, affectivity and transcendence). Finally, a celebration and farewell round of 10 minutes was held. At the end of each session, the participants were asked to share their experiences with the rest of the group.

Locations

Country Name City State
Spain Universidad de Almería Almería

Sponsors (1)

Lead Sponsor Collaborator
Universidad de Almeria

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sexual desire Sexual Desire Inventory (SDI) formed by 13 items, divided into dyadic sexual desire (Dyadic SD) (items 1-9) and solitary sexual desire (Solitary SD) (items 10-13), and valued by a Likert scale according to frequency (0 = never, and 7 = more than once a day), and intensity (0 = not desire, and 8 = strong desire), in a total range between 0 and 101 points, being higher the desire the greater the response result. 3 months
Primary Sexual excitement/sexual inhibition Sexual Inhibition/Sexual Excitement Scales - Short Form consists of 14 items with responses assessed using a Likert scale 1-4 (1 = completely agree; 4 = completely disagree) that measure three sub-scales: Sexual Excitation Scale (SES) (items 1, 3, 8, 10, 11, 14) with a score range between 4 and 16; Sexual Inhibition Scale 1 (SIS1) (items 4, 9, 12, 13) related to distraction/concentration in sexual performance, with a range between 4 and 16, and Sexual Inhibition Scale 2 (SIS2) (items 2, 5, 6, 7) related to the fear to be discovered or to contract some type of sexually transmitted infection (STI), with a range between 4 and 16. 3 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06445855 - The Effectiveness of Online Interpersonal Relationships-Based Pyschoeducation in Increasing Sexual Interest and Arousal in Women With Sexual Interest and Arousal Disorder N/A
Recruiting NCT05039775 - Clitoral Therapy Device in Alleviating Sexual Dysfunction After Genital Mutilation. N/A
Completed NCT02570282 - Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder Phase 2
Recruiting NCT05765487 - Using Thermography to Assess the Affects of Sildenafil Cream, 3.6% Phase 1
Not yet recruiting NCT02059798 - Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy N/A
Completed NCT04566783 - Identification of Etiopathological and Clinical Factors in Persistent Genital Arousal Disorder
Completed NCT03592121 - Study to Investigate the Effect of AB-101 in Breast Cancer Survivors Early Phase 1
Completed NCT00746967 - An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder Phase 2
Completed NCT00425256 - Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) Phase 2
Completed NCT04673708 - H - Test Usage in Identification of Sexual Orientation Among People. N/A